AstraZeneca reveals insurance fraud probe in China as officials say they've made criminal arrests

AstraZeneca China last month met with government officials as part of an investigation into alleged insurance fraud, the company said Friday. The probe—and subsequent arrests—hinge on suspicions that AZ China staff members tampered with genetic testing results of cancer patients in order to defraud medical insurance funds, China's National Healthcare Security Administration (NHSA) said in its release.